169 related articles for article (PubMed ID: 31088529)
1. Circulating cell-free DNA use for diagnosing cholangiocarcinoma.
Sorscher S
Clin Epigenetics; 2019 May; 11(1):75. PubMed ID: 31088529
[No Abstract] [Full Text] [Related]
2. Serum cell-free DNA methylation of OPCML and HOXD9 as a biomarker that may aid in differential diagnosis between cholangiocarcinoma and other biliary diseases.
Wasenang W; Chaiyarit P; Proungvitaya S; Limpaiboon T
Clin Epigenetics; 2019 Mar; 11(1):39. PubMed ID: 30832707
[TBL] [Abstract][Full Text] [Related]
3. Validation of methylation-sensitive high resolution melting for the detection of DNA methylation in cholangiocarcinoma.
Amornpisutt R; Sriraksa R; Limpaiboon T
Clin Biochem; 2012 Sep; 45(13-14):1092-4. PubMed ID: 22569599
[TBL] [Abstract][Full Text] [Related]
4. Targeting the Sequences of Circulating Tumor DNA of Cholangiocarcinomas and Its Applications and Limitations in Clinical Practice.
Kim KH; Yi HS; Lee H; Bae GE; Yeo MK
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108676
[TBL] [Abstract][Full Text] [Related]
5. 14-3-3sigma negatively regulates the cell cycle, and its down-regulation is associated with poor outcome in intrahepatic cholangiocarcinoma.
Kuroda Y; Aishima S; Taketomi A; Nishihara Y; Iguchi T; Taguchi K; Maehara Y; Tsuneyoshi M
Hum Pathol; 2007 Jul; 38(7):1014-1022. PubMed ID: 17391729
[TBL] [Abstract][Full Text] [Related]
6. Histopathology of a benign bile duct lesion in the liver: Morphologic mimicker or precursor of intrahepatic cholangiocarcinoma.
Lee KB
Clin Mol Hepatol; 2016 Sep; 22(3):400-405. PubMed ID: 27729636
[TBL] [Abstract][Full Text] [Related]
7. DLEC1 methylation is associated with a better clinical outcome in patients with intrahepatic cholangiocarcinoma of the small duct subtype.
Kim Y; Lee K; Jeong S; Wen X; Cho NY; Kang GH
Virchows Arch; 2019 Jul; 475(1):49-58. PubMed ID: 30610381
[TBL] [Abstract][Full Text] [Related]
8. The Role of Biliary Carcinoembryonic Antigen-Related Cellular Adhesion Molecule 6 (CEACAM6) as a Biomarker in Cholangiocarcinoma.
Rose JB; Correa-Gallego C; Li Y; Nelson J; Alseidi A; Helton WS; Allen PJ; D'Angelica MI; DeMatteo RP; Fong Y; Kingham TP; Kowdley KV; Jarnagin WR; Rocha FG
PLoS One; 2016; 11(3):e0150195. PubMed ID: 26974538
[TBL] [Abstract][Full Text] [Related]
9. Cholangiocarcinoma.
Krasinskas AM
Surg Pathol Clin; 2018 Jun; 11(2):403-429. PubMed ID: 29751883
[TBL] [Abstract][Full Text] [Related]
10. Expression of tenascin, type IV collagen and laminin during human intrahepatic bile duct development and in intrahepatic cholangiocarcinoma.
Terada T; Nakanuma Y
Histopathology; 1994 Aug; 25(2):143-50. PubMed ID: 7527010
[TBL] [Abstract][Full Text] [Related]
11. Methylation profiles of multiple CpG island loci in extrahepatic cholangiocarcinoma versus those of intrahepatic cholangiocarcinomas.
Kim BH; Cho NY; Choi M; Lee S; Jang JJ; Kang GH
Arch Pathol Lab Med; 2007 Jun; 131(6):923-30. PubMed ID: 17550320
[TBL] [Abstract][Full Text] [Related]
12. Role of epigenetic alterations in cholangiocarcinoma.
Tischoff I; Wittekind C; Tannapfel A
J Hepatobiliary Pancreat Surg; 2006; 13(4):274-9. PubMed ID: 16858537
[TBL] [Abstract][Full Text] [Related]
13. Bile carcinoembryonic cell adhesion molecule 6 (CEAM6) as a biomarker of malignant biliary stenoses.
Farina A; Dumonceau JM; Antinori P; Annessi-Ramseyer I; Frossard JL; Hochstrasser DF; Delhaye M; Lescuyer P
Biochim Biophys Acta; 2014 May; 1844(5):1018-25. PubMed ID: 23806607
[TBL] [Abstract][Full Text] [Related]
14. An immunostaining panel of C-reactive protein, N-cadherin, and S100 calcium binding protein P is useful for intrahepatic cholangiocarcinoma subtyping.
Akita M; Sawada R; Komatsu M; Suleman N; Itoh T; Ajiki T; Heaton N; Fukumoto T; Zen Y
Hum Pathol; 2021 Mar; 109():45-52. PubMed ID: 33321161
[TBL] [Abstract][Full Text] [Related]
15. Genetic and epigenetic changes associated with cholangiocarcinoma: from DNA methylation to microRNAs.
Stutes M; Tran S; DeMorrow S
World J Gastroenterol; 2007 Dec; 13(48):6465-9. PubMed ID: 18161915
[TBL] [Abstract][Full Text] [Related]
16. Biliary ascariasis and extrahepatic cholangiocarcinoma.
Toufeeq Khan TF; Muniandy S
Singapore Med J; 1995 Oct; 36(5):570. PubMed ID: 8882553
[No Abstract] [Full Text] [Related]
17. Usefulness of 18F-fluorodeoxyglucose positron emission tomography in differential diagnosis and staging of cholangiocarcinomas.
Moon CM; Bang S; Chung JB; Park SW; Song SY; Yun M; Lee JD
J Gastroenterol Hepatol; 2008 May; 23(5):759-65. PubMed ID: 17931372
[TBL] [Abstract][Full Text] [Related]
18. Analysis of white bile in a case of cholangiocarcinoma of the hepatic ducts.
GRIFFITHS DB; HABER MH; REES KR; SMITH JF
J Pathol Bacteriol; 1963 Apr; 85():389-93. PubMed ID: 13950420
[No Abstract] [Full Text] [Related]
19. Epithelial cell adhesion molecule is a prognosis marker for intrahepatic cholangiocarcinoma.
Sulpice L; Rayar M; Turlin B; Boucher E; Bellaud P; Desille M; Meunier B; Clément B; Boudjema K; Coulouarn C
J Surg Res; 2014 Nov; 192(1):117-23. PubMed ID: 24909871
[TBL] [Abstract][Full Text] [Related]
20. Clear cell cholangiocarcinoma of the liver is a morphologically distinctive entity.
Logani S; Adsay V
Hum Pathol; 1998 Dec; 29(12):1548-9. PubMed ID: 9865848
[No Abstract] [Full Text] [Related]
[Next] [New Search]
